Sequana Medical Announces the Completion of alfapump Implantations in POSEIDON, the North American Pivotal alfapump Study
Figure 1 Kaplan Meier – Preliminary survival rate analysis of Roll-In Cohort, dated 25 March…
Figure 1 Kaplan Meier – Preliminary survival rate analysis of Roll-In Cohort, dated 25 March…
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) — Curium announced today that its generic version…
Interim data suggest long-term treatment with VYVGART provides improvement in generalized myasthenia gravis (gMG)…
Pilot aims to streamline handoff from warehouse inventory robots to picking robots so that businesses…
Acquisition Brings Advanced, AI powered Omnichannel Conversational Engagement Solutions to BFSI Organizations SAN FRANCISCO &…
Tony Fadell’s Future Shape also joins Series B round Company has raised $100 million in…
JAKARTA, Indonesia–(BUSINESS WIRE)–PT Freeport Indonesia (“PT-FI” or the “Company”) announced today that it intends to…
ZURICH, SWITZERLAND, Apr 5, 2022 – (JCN Newswire) – Hitachi Energy today launched its OceaniQ…
TOKYO, Apr 5, 2022 – (JCN Newswire) – Fujitsu today announced the development and deployment…
TOKYO, Apr 5, 2022 – (JCN Newswire) – NTT DOCOMO, INC. announced today that it…
Speeds of over 1 Gbps in 5G Non-Standalone configuration validating the growing maturity of Open…
FORT WORTH, TX, April 04, 2022 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” the “Company,”…
Singapore, Apr 5, 2022 – (ACN Newswire) – 2022 continues to be a challenging year…
NEW YORK–(BUSINESS WIRE)–Labaton Sucharow LLP (“Labaton Sucharow”) announces that on April 4, 2022, it filed…
GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC),…
Annual Report on Form 10-K for fiscal year ended December 31, 2021 to be filed…
Data from NOVA study further support the efficacy and safety of natalizumab IV when administered…
CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today…
WALTHAM, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology…
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…